Suppr超能文献

进一步探讨针对细胞耐药性的抗肿瘤药物设计方法:关注氮杂冠醚-dtc 配合物。

Further Approaches in the Design of Antitumor Agents with Response to Cell Resistance: Looking toward Aza Crown Ether-dtc Complexes.

机构信息

Grupo METMED, Departamento de Quı́mica & Centro de Investigaciones Cientı́ficas Avanzadas (CICA), Universidade da Coruña, Campus da Zapateira s/n, 15071 A Coruña, Spain.

Centro de Investigaciones Quı́micas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, C.P., 62209 Cuernavaca, Morelos, Mexico.

出版信息

Inorg Chem. 2020 Oct 19;59(20):15120-15134. doi: 10.1021/acs.inorgchem.0c02068. Epub 2020 Oct 1.

Abstract

The dianionic aza crown ether-dtc ,'-bis(dithiocarbamate)-1,10-diaza-18-crown-6 () is a versatile ligand capable of yielding binuclear complexes with group 10 elements, also known as Ni-triade, [μ-(κ'-)M(PPh)]Cl (M = Pd (), Pt ()), μ-(κ'-L)M(PPh) (M = Pd (), Pt ()), and μ-('-L)Ni(PPh)Cl (), and has proven to be an excellent option to the design of metal-based drugs able to provide multiple response to cell resistance. Palladium and platinum complexes, and , were tested for cytotoxicity in the human cervix carcinoma cell line HeLa-229, the human ovarian carcinoma cell line A2780, and the cisplatin-resistant mutant A2780, finding significant activity toward all three cancer cell lines, with low micromolar IC values, comparable to cisplatin. Markedly, against the cisplatin resistant cell line A2780, compound exhibits better cytotoxic activity than the clinical drug (IC = 2.3 ± 0.2 μM for versus 3.6 ± 0.5 μM for cisplatin). Moreover, an enhancement of the antitumor response is achieved when adding an equimolar amount of alkali metal chloride (NaCl or KCl) to the medium, for instance, testing compound against the cisplatin-resistant A2780 cells, the IC decreases from 9.3 ± 0.4 to 7.4 ± 0.3 and 5.4 ± 0.1 μM, respectively, after addition of the salt solution. For the platinum derivative , the IC improves by ca. 40% reaching 1.3 ± 0.1 μM when potassium chloride is added. Likewise, the resistant factor found for (RF = 1) confirms that this complex circumvents cisplatin-resistance in A2780 and is improved with the addition of potassium chloride (RF = 0.65). The presence of the aza crown ether moiety as linker in the systems studied herein is a key point since, in addition to allowing and facilitating interaction with alkali metal ions, this unit is flexible enough to adapt to a variety of environments, as confirmed by the X-ray crystal structures described, where different conformations and ways to fold in are found. In order to gain insight into the electronic and structural facts involved in the interaction of complex with the alkali metal ions, a DFT study was performed, and the description of the molecular electrostatic potentials (MEPs) is also presented.

摘要

双阴离子氮杂冠醚-dtc(-双(硫代氨基甲酸盐)-1,10-二氮杂-18-冠-6())是一种多功能配体,能够与第 10 族元素形成双核配合物,也称为 Ni-三唑,[μ-(κ'-)M(PPh)]Cl(M = Pd(),Pt()),[μ-(κ'-L)M(PPh)](BPh)(M = Pd(),Pt())和μ-('-L)Ni(PPh)Cl(),并且已被证明是设计能够提供对细胞耐药性的多种反应的金属基药物的绝佳选择。钯和铂配合物和被测试对人宫颈癌细胞系 HeLa-229、人卵巢癌细胞系 A2780 和顺铂耐药突变体 A2780 的细胞毒性,发现对所有三种癌细胞系均具有显著的活性,其 IC 值低至微摩尔,与顺铂相当。值得注意的是,与顺铂耐药细胞系 A2780 相比,化合物表现出比临床药物更好的细胞毒性活性(IC = 2.3 ± 0.2 μM 用于,而 3.6 ± 0.5 μM 用于顺铂)。此外,当向培养基中添加等摩尔量的碱金属氯化物(NaCl 或 KCl)时,可增强抗肿瘤反应,例如,用化合物测试顺铂耐药 A2780 细胞时,IC 从 9.3 ± 0.4 降至 7.4 ± 0.3 和 5.4 ± 0.1 μM,分别在添加盐溶液后。对于铂衍生物,当添加氯化钾时,IC 提高了约 40%,达到 1.3 ± 0.1 μM。同样,对于发现的耐药因子(RF = 1),证实该配合物可规避 A2780 中的顺铂耐药性,并通过添加氯化钾得到改善(RF = 0.65)。在所研究的系统中,氮杂冠醚作为连接体的存在是一个关键点,因为除了允许和促进与碱金属离子的相互作用外,该单元足够灵活,可以适应各种环境,正如所描述的 X 射线晶体结构所证实的那样,其中发现了不同的构象和折叠方式。为了深入了解配合物与碱金属离子相互作用所涉及的电子和结构事实,进行了 DFT 研究,并呈现了分子静电势(MEP)的描述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验